Transaxillary Endoscopic Approach to Capsular Contracture Following Previous Breast Augmentation: Operative Technique and Clinical Outcome

Liu, Chang; Chen, Yuzhe; Xu, Yan; Qu, Qi; Wang, Zijun; Yang, Fan

doi:10.1007/s00266-019-01525-z

Cited by 10 publications

(14 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…81 However, the endoscopic assisted transaxillary approach seems to lower complications by minimizing bleeding and surgical trauma. 82…”

Section: Discussionmentioning

confidence: 99%

Advances on Capsular Contracture—Prevention and Management Strategies: A Narrative Review of the Literature

Susini,

Nisi,

Pierazzi

et al. 2023

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

Background: Capsular contracture (CC) is the most relevant complication of both aesthetic and reconstructive breast implant surgery. For many years, experimental and clinical trials have attempted to analyze CC risk factors, clinical features, and appropriate management strategies. It is commonly accepted that a multifactorial etiology promotes CC development. However, the heterogeneity in patients, implants and surgical techniques make it difficult to suitably compare or analyze specific factors. As a consequence, discordant data are present in literature, and a true systematic review is often limited in its conclusions. Hence, we decided to present a comprehensive review of current theories on prevention and management strategies, rather than a specific “solution” to this complication. Methods: The PubMed database was searched for literature regarding CC prevention and management strategies. Pertinent articles in English, published before December 1, 2022, were compared with selection criteria and eventually included in this review. Results: Through the initial search, 97 articles were identified, of which 38 were included in the final study. Several articles explored different medical and surgical preventive and therapeutic strategies, showing numerous controversies on appropriate CC management. Conclusions: This review provides a clear overview of the complexity of CC. The wide variety of clinical situations in term of patients, implants, and surgical techniques prevent the standardization of CC management strategies. By contrast, a patient-customized approach should be preferred, and different strategies should be considered depending on the specific case. Further research is desirable to better ascertain evidence-based protocols with regard to CC prevention and treatment.

show abstract

“…81 However, the endoscopic assisted transaxillary approach seems to lower complications by minimizing bleeding and surgical trauma. 82…”

Section: Discussionmentioning

confidence: 99%

Advances on Capsular Contracture—Prevention and Management Strategies: A Narrative Review of the Literature

Susini,

Nisi,

Pierazzi

et al. 2023

Plastic and Reconstructive Surgery - Global Open

View full text Add to dashboard Cite

show abstract

“…Several medical centers have veri ed its feasibility and safety using same method. [19][20][21][22] It reaches threefold advantages of minimal invasion, and function and cosmetic. It also gains two aims in physiologically and psychologically minimal invasion.…”

Section: Discussionmentioning

confidence: 99%

17-Year Follow-Up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicentres, Randomized Controlled Trial

Luo

Cao

Guo

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: Longer follow-up was necessary to testify the exact value of mastoscopic axillary lymph node dissection (MALND).Methods：From January 1, 2003 to December 31, 2005, 1027 patients with breast cancer were randomly assigned to two groups: MALND and CALND (conventional axillary lymph node dissection). 996 eligible patients were enrolled.Results：The final cohort of 996 patients was followed for an average of 198 months. The events other than death differed significantly between the two cohorts（p=0.0311） (46.3% in MALND and 53.2% in CALND, respectively). The sum of the events other than death and deaths from other causes was much more in CALND （59.6%）than in MALND (53.4%）（p=0.0494）. The 17-year DFS rates were 36.7 percent for MALND group and 33.6 percent for CALND group，respectively. There was a signiﬁcant difference between the groups (p=.0306). The OS rates were 53.2 percent after MALND and 46.0 percent after CALND ( p= .0119). The MALND patients had much less axillary pain (p =. 0000), numbness or paresthesia (p = .0000) ，arm mobility (p =. 0000), and arm swelling on operated side (p = .0000). The aesthetic appearance of axilla in MALND group was much better than that in CALND group (p =. 0000) at an average follow-up of 17-year.Conclusions：The use of MALND in breast cancer surgery not only decreases the relapse and arm complications but also improves long-term survival of patients. Therefore, MALND should be one of the preferred approaches for breast cancer surgery when ALND is needed.

show abstract

“…Several medical centers have veri ed its feasibility and safety using same method. [11][12][13][14][15][16] The lymph nodes number harvested, postoperative symptoms, drainage time and drainage liquid in MALND compared to those in CALND are no signi cantly differences. But long-term complications such as upper limb dysfunction, serious pain, edema and activity complications reduced obviously in MALND.…”

Section: Discussionmentioning

confidence: 99%

“…Moreover, some authors also have done a series of work on mastoscopic SLNB, singleport, 3D and robotic MALND. 13,[14][15][16][17][18][19][20] They all stated that this technique could be a promising alternative to conventional methods.…”

Section: Discussionmentioning

confidence: 99%

15-year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicentres, Randomized Controlled Trial

Luo

Cao

Guo

et al. 2020

Preprint

View full text Add to dashboard Cite

Backgroud: Longer follow-up was necessary to testify the exact value of mastoscopic axillary lymph node dissection (MALND).Methods：From January 1, 2003 to December 31, 2005,1027 patients with operable breast cancer were randomly assigned to two groups: MALND and CALND. 996 eligible patients were enrolled. The end points are disease free survival and overall survival.Results：The final cohort of 996 patients was followed for an average of 184 months. The distribution of all events was fairly similar between two groups of patients. The incidence of local in-breast events did not differ in a significant manner between two cohorts. Similarly, the rate of distant metastases was not significantly different with 30.0% in MLND and 32.6% in CALND. And no significant difference was observed in other primary tumor between two groups (p=0.46). Patients who remain alive with no event comprise a total of 37.2% in MALND and 35.4% in CALND. Other primary cancers and deaths from other causes were distributed equally between two groups. The 15-year disease-free survival rates were41.1 percent for the MALND group and 39.6 percent for the CALND group (p=0.79). MALND was found to be not inferior for overall survival (P =0.54). The 15-year overall survival rates were 49.5 percentafter MALND and 51.2 percentafter CALND (p=0.86). Probability of overall survival was not significantly different between two groups.Conclusions：MALND does not increase unfavorable events, and also does not affect the long-term survival of patients. Therefore, MALND should be one of the preferred approaches for breast cancer surgery.

show abstract

Transaxillary Endoscopic Approach to Capsular Contracture Following Previous Breast Augmentation: Operative Technique and Clinical Outcome

Cited by 10 publications

References 16 publications

Advances on Capsular Contracture—Prevention and Management Strategies: A Narrative Review of the Literature

Advances on Capsular Contracture—Prevention and Management Strategies: A Narrative Review of the Literature

17-Year Follow-Up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicentres, Randomized Controlled Trial

15-year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicentres, Randomized Controlled Trial

Contact Info

Product

Resources

About